Nihanthy Sreenath
@nihanthy
Followers
72
Following
97
Media
1
Statuses
34
🎗️ Medical Oncologist | 🎓 Cancer Educator | 🧬 AYA, Breast, Gyn, GI Cancers | 💉 BMT & CAR-T | Passionate about evidence, equity & empathy in oncology
Kolkata
Joined January 2010
RT @OncBrothers: Treatment Algorithm: This is the algorithm we have used during our discussion w/ @JohnPLeonardMD for DLBCL . #OncTwitter #….
0
39
0
RT @KVanLoonMD: See this amazing example from @NEJM by Dr. Nihanthy D. Sreenath @nihanthy for inspiration: A Good Innings — A Tale of Hope,….
nejm.org
A pediatric oncologist’s outlook and practice are transformed when a 10-year-old cricket fanatic with acute lymphoblastic leukemia touches her heart.
0
1
0
Thank you to MASCC and OncoDaily. Grateful to be featured by @OncoDaily1 among global leaders in supportive oncology through the Multinational Association of Supportive Care in Cancer (MASCC). 🌍💙.#MASCC #Oncology #SupportiveCare.
📢25 Posts Not To Miss From MASCC 2025. @CancerCareMASCC .@iankleckner | @DarcyBurbage | @stage4kelly | @coffeemommy | @Dr_Rahul_AIIMS | @drmpk91 | @chitchadkitchen | @dquin_ng | @fumikochino | @HelsinnGroup | @JordanCurry2 | @DrNicolasHart | @nihanthy | @villa_dds
0
0
3
RT @oncodaily: 📢25 Posts Not To Miss From MASCC 2025. @CancerCareMASCC .@iankleckner | @DarcyBurbage | @stage4kelly | @coffeemommy | @Dr_Ra….
0
12
0
Thank you to MASCC and OncoDaily. Grateful to be featured by @OncoDaily1 among global leaders in supportive oncology through the Multinational Association of Supportive Care in Cancer (MASCC). 🌍💙.#MASCC #Oncology #SupportiveCare.
Greatful to be featured in @OncoDaily’s 25 must-see posts from #MASCC2025! #Oncology #CancerCare.@CancerCareMASCC @drmpk91 @nihanthy @saadnasir01.
0
0
2
RT @Dr_Rahul_AIIMS: Greatful to be featured in @OncoDaily’s 25 must-see posts from #MASCC2025! #Oncology #CancerCare.@CancerCareMASCC @drmp….
0
1
0
What a ride, Saad! 🎤🔥 Your energy lit up #MASCC2025-proud to cheer you on through it all. Grateful for the science, the friendship, and the shared purpose in oncology & supportive care! 🌟.
Just wrapped up #MASCC2025 ✨ Presented x2 🎤📊, found an inspiring mentor @maryam_lustberg 🌟, made amazing friends (@Dr_Rahul_AIIMS, @nihanthy, @drmpk91) 🤝, and embraced Seattle’s vibes. Grateful 🙏 for the science, the stories, and a whole new lens on supportive care.
1
1
5
RT @saadnasir01: Just wrapped up #MASCC2025 ✨ Presented x2 🎤📊, found an inspiring mentor @maryam_lustberg 🌟, made amazing friends (@Dr_Rahu….
0
3
0
Honoured to present on psychosocial distress in AYA cancer patients at #MASCC2025 - a topic close to my heart. Grateful to my mentors. Proud to see 🇮🇳 shine - kudos to Dr. Praveen & Dr. Rahul for brilliant work on Mind & Money & scalp cooling in pediatric oncology. #AYAOncology
3
2
21
RT @SuyogCancer: Honored to be named among the Top 10 Digital Opinion Leaders at ASCO 2025 by @Larvol. In a time where borders blur in the….
0
12
0
RT @samdoc_mamc: Pleased to share Phase 2 trial results for low-dose regorafenib in relapsed synovial sarcoma. N=25, 76% previously expose….
0
14
0
RT @SuyogCancer: When you treat metastatic CRPC in elderly person, polypharmacy and drug to drug interactions needs to noted . These are s….
0
36
0
RT @SuyogCancer: Excellent summary slides for current evidence for pancreatic cancer treatment . Useful for quick reference. @asco #asco25….
0
137
0
RT @VivekSubbiah: ⭐️🚨Delighted to report 👉🏼Efficacy and safety of pralsetinib in RET fusion-positive solid tumors: Final data from the ARRO….
ascopubs.org
3116Background: Pralsetinib is an oral tyrosine kinase inhibitor that selectively and potently targets oncogenic RET fusion and mutation proteins. RET fusions or mutations are present in various...
0
7
0
RT @samdoc_mamc: We are pleased to share the preliminary results of SORASTOP, which investigates whether sorafenib can be discontinued in i….
0
8
0
RT @SachinSarcoma: Organised 263 th #sarcoma #supportgroup meeting on last Sunday where Dr @nihanthy gave talk on How to deal with sideeffe….
0
4
0
RT @SuyogCancer: As an #ASCO25 Ambassador, I’ve started posting key abstract highlights on X — and will continue over the coming days!.🌍 Fo….
0
4
0
RT @SachinSarcoma: Organising 263 th #sarcoma #supportgroup meeting on this Sunday and have invited Dr Nihanthy Sreenath , #Medicaloncologi….
0
4
0